We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Abbott Yields To Brazil Pressure, Avoids Compulsory License On Kaletra

Law360 (July 10, 2005, 12:00 AM EDT) -- In a last-minute compromise that averted a compulsory license, U.S. drug maker Abbott Laboratories agreed Friday to lower the price the Brazilian government pays for its AIDS drug Kaletra.

Brazil had...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.